Says healthcare experience “still not where it needs to be.” Says entering 2026 with “significant momentum.” Says “laser focused” on improving margins in Medicare business. Comments taken from Q4 earnings conference call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health sees FY26 revenue ‘at least’ $400B, consensus $409.2B
- CVS Health backs FY26 CapEx view $3B-$3.2B
- Options Volatility and Implied Earnings Moves Today, February 10, 2026
- CVS Health reports Q4 adjusted EPS $1.09, consensus $1.00
- CVS Health backs FY26 adjusted EPS view $7.00-$7.20, consensus $7.17